The 2025 program offered a comprehensive industry-dedicated platform to connect Asia’s rapidly growing innovators in mRNA, sa-RNA, circular RNA and siRNA medicine to chart a path to success across the region.

This was an opportunity to gain actionable insights and takeaways across 3-days to roadmap the path from discovery through commercialization to develop efficacious RNA medicines for patients faster.